Cargando…

Characterization and outcomes of pulmonary alveolar proteinosis in Brazil: a case series

OBJECTIVE: Pulmonary alveolar proteinosis (PAP) is a rare disease, characterized by the alveolar accumulation of surfactant, which is composed of proteins and lipids. PAP is caused by a deficit of macrophage activity, for which the main treatment is whole-lung lavage (WLL). We report the experience...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Athayde, Rodolfo Augusto Bacelar, Arimura, Fábio Eiji, Kairalla, Ronaldo Adib, Carvalho, Carlos Roberto Ribeiro, Baldi, Bruno Guedes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2018
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188683/ https://www.ncbi.nlm.nih.gov/pubmed/30043890 http://dx.doi.org/10.1590/S1806-37562017000000168

Ejemplares similares

COVID-19 and pulmonary alveolar proteinosis: an unusual combination
por: Colares, Philippe de Figueiredo Braga, et al.
Publicado: (2022)

Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations
por: Freitas, Carolina Salim Gonçalves, et al.
Publicado: (2015)

Alveolar proteinosis of genetic origins
por: Hadchouel, Alice, et al.
Publicado: (2020)

Doxycycline use in patients with lymphangioleiomyomatosis: biomarkers and pulmonary function response ,
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2013)

Hard metal lung disease: a case series
por: Mizutani, Rafael Futoshi, et al.
Publicado: (2016)

PULMONARY ALVEOLAR PROTEINOSIS SUBMITTED A WHOLE LUNG LAVAGE AFTER COVID-19: A CASE REPORT
por: D'AMBROSIO, PAULA, et al.
Publicado: (2021)

Lung cysts in chronic paracoccidioidomycosis
por: Costa, André Nathan, et al.
Publicado: (2013)

Birt-Hogg-Dubé syndrome: metalloproteinase activity and response to doxycycline
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2012)

Desaturation – distance ratio: a new concept for a functional assessment of interstitial lung diseases
por: Pimenta, Suzana Pinheiro, et al.
Publicado: (2010)

Idiopathic pulmonary fibrosis can be a transient diagnosis
por: de Oliveira, Martina Rodrigues, et al.
Publicado: (2016)

Pulmonary alveolar proteinosis in children: a case series
por: Tabatabaei, Seyyed Ahmad, et al.
Publicado: (2010)

Atypical alveolar proteinosis
por: Rajaonarison Ny Ony Narindra, Lova Hasina, et al.
Publicado: (2018)

Adalimumab-induced acute interstitial lung disease in a patient with rheumatoid arthritis
por: Dias, Olívia Meira, et al.
Publicado: (2014)

Alveolar proteinosis in Behçet's disease
por: Tetikkurt, Cuneyt, et al.
Publicado: (2010)

Congenital Pulmonary Alveolar Proteinosis
por: Hammami, Saber, et al.
Publicado: (2013)

Pulmonary alveolar proteinosis in children
por: Bush, Andrew, et al.
Publicado: (2020)

Eosinophilic pneumonia: remember topical drugs as a potential etiology
por: Dias, Olívia Meira, et al.
Publicado: (2018)

Pulmonary alveolar proteinosis in a cat
por: Szatmári, Viktor, et al.
Publicado: (2015)

Pulmonary Alveolar Proteinosis with Ulcerative Colitis
por: Sakamoto, Noriho, et al.
Publicado: (2018)

Pulmonary alveolar proteinosis with peripheral adenocarcinom
por: Zhang, Ning, et al.
Publicado: (2018)

Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022)

Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features
por: Pereira, Daniel Antunes Silva, et al.
Publicado: (2015)

Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases
por: Baldi, Bruno Guedes, et al.
Publicado: (2021)

Immunohistological features related to functional impairment in lymphangioleiomyomatosis
por: Nascimento, Ellen Caroline Toledo do, et al.
Publicado: (2018)

Whole lung lavage for pulmonary alveolar proteinosis
por: Jayaraman, S., et al.
Publicado: (2010)

Pulmonary alveolar proteinosis: diagnostic and therapeutic challenges
por: Campo, Ilaria, et al.
Publicado: (2012)

Lung Transplant Recipient with Pulmonary Alveolar Proteinosis
por: Tokman, Sofya, et al.
Publicado: (2016)

Prevalence and healthcare burden of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)

Alveolar proteinosis due to toxic inhalation at workplace
por: Santos, Gabriela F., et al.
Publicado: (2020)

Pulmonary alveolar proteinosis: from classification to therapy
por: Salvaterra, Elena, et al.
Publicado: (2020)

Valuable Serum Markers in Pulmonary Alveolar Proteinosis
por: Shi, Shenyun, et al.
Publicado: (2019)

Pulmonary alveolar proteinosis after lung transplantation
por: Divithotawela, Chandima, et al.
Publicado: (2020)

Pulmonary alveolar proteinosis with an unusual bronchoscopic complication
por: Sweeney, Duncan J., et al.
Publicado: (2021)

Alveolar proteinosis - an underdiagnosed condition in young people
por: Chiş, Ana Florica, et al.
Publicado: (2021)

Sirolimus-induced secondary pulmonary alveolar proteinosis
por: Wang, Stephanie, et al.
Publicado: (2021)

Alveolar Proteinosis in COVID-19: Clinical Case
por: Martin Bote, Silvia, et al.
Publicado: (2022)

Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies
por: Huang, Xinmei, et al.
Publicado: (2023)

Impaired lipid metabolism in idiopathic pulmonary alveolar proteinosis
por: Tian, Xinlun, et al.
Publicado: (2011)

Pulmonary alveolar proteinosis treatment by whole-lung lavage
por: Cai, Chang, et al.
Publicado: (2012)

Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis
por: McCarthy, Cormac, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9n1gpff6bsguvlbpniluvjrrm1